tiprankstipranks
Advertisement
Advertisement
Chemomab Highlights New Nebokitug Data in PSC as Q1 2026 Update Underscores PSC–IBD Potential
PremiumCompany AnnouncementsChemomab Highlights New Nebokitug Data in PSC as Q1 2026 Update Underscores PSC–IBD Potential
3M ago
Chemomab Shareholders Approve Governance Resolutions and Capital Increase at May 5 Meeting
Premium
Company Announcements
Chemomab Shareholders Approve Governance Resolutions and Capital Increase at May 5 Meeting
3M ago
Chemomab Adjourns April 28 Shareholder Meeting to May 5 After Quorum Shortfall
Premium
Company Announcements
Chemomab Adjourns April 28 Shareholder Meeting to May 5 After Quorum Shortfall
4M ago
Chemomab Therapeutics announces results of its Phase 2 SPRING trial
PremiumThe FlyChemomab Therapeutics announces results of its Phase 2 SPRING trial
9M ago
Chemomab Therapeutics Advances PSC Treatment with Phase 3 Trial
Premium
Company Announcements
Chemomab Therapeutics Advances PSC Treatment with Phase 3 Trial
9M ago
Chemomab Therapeutics Advances Nebokitug Phase 3 Trial with Regulatory Support
Premium
Company Announcements
Chemomab Therapeutics Advances Nebokitug Phase 3 Trial with Regulatory Support
9M ago
Chemomab Therapeutics management to meet with Maxim
PremiumThe FlyChemomab Therapeutics management to meet with Maxim
11M ago
Chemomab Therapeutics price target raised to $25 from $10 at Oppenheimer
Premium
The Fly
Chemomab Therapeutics price target raised to $25 from $10 at Oppenheimer
12M ago
Chemomab Therapeutics Ltd – ADR trading halted, news pending
Premium
The Fly
Chemomab Therapeutics Ltd – ADR trading halted, news pending
12M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100